Use of amide derivative of ge 2270 factor a3 for the treatment of acne
CA 2489705 C · Owner: Malabarba, Adriano · Inventors: Malabarba, Adriano; Cavaleri, Marco; Mosconi, Giorgio
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Use of the compound of formula (I) and the pharmaceutically acceptable addition salts thereof for the manufacture of a medicament for topical treatment or 5 prevention of acne formula (I) wherein: R represents methoxymethyl, R1 represents methyl, Rz represents methyl Y represents the , group formula (II) The compound of formula (I) and the pharmaceutically acid addition salts thereof show selective activity against propionibacterium acne and are suitable for use in a method of treament or prevention of acne.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 6, 2003 and granted August 14, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 6, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 6, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.